portrazza

Generic: necitumumab

Labeler: eli lilly and company
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name portrazza
Generic Name necitumumab
Labeler eli lilly and company
Dosage Form SOLUTION
Routes
INTRAVENOUS
Active Ingredients

necitumumab 16 mg/mL

Manufacturer
Eli Lilly and Company

Identifiers & Regulatory

Product NDC 0002-7716
Product ID 0002-7716_2e3ca40c-550b-4303-991e-b6c849aec30c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA125547
Marketing Start 2015-11-24
Marketing End 2026-05-27

Pharmacologic Class

Established (EPC)
epidermal growth factor receptor antagonist [epc]
Mechanism of Action
her1 antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00027716
Hyphenated Format 0002-7716

Supplemental Identifiers

RxCUI
1723745 1723750
UNII
2BT4C47RUI
NUI
N0000175664 N0000020010

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name portrazza (source: ndc)
Generic Name necitumumab (source: ndc)
Application Number BLA125547 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 16 mg/mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-USE in 1 CARTON (0002-7716-01) / 50 mL in 1 VIAL, SINGLE-USE
source: ndc

Packages (1)

0002-7716-01 1 VIAL, SINGLE-USE in 1 CARTON (0002-7716-01) / 50 mL in 1 VIAL, SINGLE-USE

Ingredients (1)

necitumumab (16 mg/mL)

Linked Drug Pages (1)

Portrazza ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "2e3ca40c-550b-4303-991e-b6c849aec30c", "openfda": {"nui": ["N0000175664", "N0000020010"], "unii": ["2BT4C47RUI"], "rxcui": ["1723745", "1723750"], "spl_set_id": ["89bcf553-669a-40b0-a9d7-67a5c1d2f591"], "pharm_class_epc": ["Epidermal Growth Factor Receptor Antagonist [EPC]"], "pharm_class_moa": ["HER1 Antagonists [MoA]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (0002-7716-01)  / 50 mL in 1 VIAL, SINGLE-USE", "package_ndc": "0002-7716-01", "marketing_end_date": "20260527", "marketing_start_date": "20151124"}], "brand_name": "Portrazza", "product_id": "0002-7716_2e3ca40c-550b-4303-991e-b6c849aec30c", "dosage_form": "SOLUTION", "pharm_class": ["Epidermal Growth Factor Receptor Antagonist [EPC]", "HER1 Antagonists [MoA]"], "product_ndc": "0002-7716", "generic_name": "necitumumab", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Portrazza", "active_ingredients": [{"name": "NECITUMUMAB", "strength": "16 mg/mL"}], "application_number": "BLA125547", "marketing_category": "BLA", "marketing_end_date": "20260527", "marketing_start_date": "20151124"}